Cutting-edge research in gene therapy, light therapy, and AI is redefining how we understand and treat Age-Related Macular Degeneration, offering hope for lasting vision.
In a groundbreaking move, the United States Food and Drug Administration has recently given its nod to two pioneering cell-based gene therapies, Casgevy and